Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMesoblast Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q4 2026 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q1 2027 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2027 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2027 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2028 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2028 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2028 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q4 2028 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q1 2029 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q2 2029 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2029 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2029 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2030 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2030 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2030 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2030 | 1 | $0.08 | $0.08 | $0.08 |
| Q1 2031 | 1 | $0.17 | $0.17 | $0.17 |
| Q2 2031 | 1 | $1.06 | $1.06 | $1.06 |
| Q3 2031 | 1 | $0.62 | $0.62 | $0.62 |
Mesoblast Ltd Earnings Date And Information
Mesoblast Ltd last posted its earnings results on Thursday, February 26th, 2026. The company reported $-0.311 earnings per share for the quarter, missing analysts' consensus estimates of $-0.237 by $0.074. The company had revenue of 7.02 M for the quarter and had revenue of 17.20 M for the year. Mesoblast Ltd has generated $-1 earnings per share over the last year ($-0.84 diluted earnings per share) and currently has a price-to-earnings ratio of -23.65. Mesoblast Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Mesoblast Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/29/2025 | Q4 2025 | N/A | -$0.21 | N/A | $9.05 M | $7.02 M |
| 03/31/2025 | Q3 2025 | N/A | -$0.21 | N/A | N/A | $7.02 M |
| 02/27/2025 | Q2 2025 | N/A | -$0.21 | N/A | N/A | $1.58 M |
| 10/17/2024 | Q1 2025 | N/A | -$0.21 | N/A | $1.52 M | $1.58 M |
| 08/29/2024 | Q4 2024 | N/A | -$0.25 | N/A | $1.52 M | $1.26 M |
| 03/31/2024 | Q3 2024 | N/A | -$0.25 | N/A | N/A | $1.26 M |
| 12/30/2023 | Q2 2024 | N/A | -$0.19 | N/A | N/A | $1.69 M |
| 09/29/2023 | Q1 2024 | N/A | -$0.19 | N/A | N/A | $1.69 M |
| 06/29/2023 | Q4 2023 | N/A | -$0.23 | N/A | N/A | $2.14 M |
| 03/30/2023 | Q3 2023 | N/A | -$0.25 | N/A | N/A | $1.94 M |
| 12/30/2022 | Q2 2023 | N/A | -$0.32 | N/A | N/A | $1.98 M |
| 09/29/2022 | Q1 2023 | N/A | -$0.24 | N/A | N/A | $1.44 M |
| 06/29/2022 | Q4 2022 | N/A | -$0.33 | N/A | N/A | $2.22 M |
| 03/30/2022 | Q3 2022 | N/A | -$0.33 | N/A | N/A | $2.01 M |
| 12/30/2021 | Q2 2022 | N/A | -$0.40 | N/A | N/A | $2.38 M |
| 09/29/2021 | Q1 2022 | N/A | -$0.35 | N/A | N/A | $3.59 M |
| 06/29/2021 | Q4 2021 | N/A | -$0.34 | N/A | N/A | $2.00 M |
| 03/30/2021 | Q3 2021 | N/A | -$0.44 | N/A | N/A | $1.91 M |
| 12/30/2020 | Q2 2021 | N/A | -$0.44 | N/A | N/A | $2.24 M |
| 09/29/2020 | Q1 2021 | N/A | -$0.42 | N/A | N/A | $1.29 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mesoblast Ltd Earnings: FAQ's
The conference call for Mesoblast Ltd's latest earnings report can be listened to online.
The conference call transcript for Mesoblast Ltd's latest earnings report can be read online.
Mesoblast Ltd (:MESO) has a recorded annual revenue of $17.20 M.
Mesoblast Ltd (:MESO) has a recorded net income of $-102,142,000.Mesoblast Ltd has generated $-0.84 earnings per share over the last four quarters.
Mesoblast Ltd (:MESO) has a price-to-earnings ratio of -23.65 and price/earnings-to-growth ratio is -7.5.